The New England Compounding Center (NECC) has issued a recall of certain lots of steroid injection after reports of fungal meningitis (from Aspergillus fumigatus, Exserohilum and possibly other fungi) and stroke associated with the product, methylprednisolone acetate infection. The outbreak of fungal meningitis and stroke has sickened people in Tennessee, Virginia, Indiana, Maryland, Michigan, Minnesota, New Jersey, North Carolina Ohio, and Florida. Most of the people sickened are from the Nashville area. Seven people have died in this outbreak to date.
Lawyers Fred Pritzker and David Szerlag recently won over $40,0o0,000 for clients injured by another medical product and are now investigating this outbreak. Contact them here for a free consultation regarding a steroid meningitis lawsuit for personal injury or wrongful death against NECC and possibly others.
All fungal meningitis patients received injection with preservative-free methylprednisolone acetate (80mg/ml) prepared by New England Compounding Center, located in Framingham, MA. Many of these patients also had a stroke.
On September 25, 2012, the New England Compounding Center located in Framingham, MA voluntarily recalled the following lots of methylprednisolone acetate (PF) 80mg/ml:
- Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@68, BUD 11/17/2012
- Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #06292012@26, BUD 12/26/2012
- Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #08102012@51, BUD 2/6/2013
On October 3, 2012, the compounding center ceased all production and initiated recall of all methylprednisolone acetate and other drug products prepared for intrathecal administration.
Expansion of Methylprednisolone Acetate recall
- Methylprednisolone Acetate (PF) 40 mg/ml, Lot #05012012@74, 06082012@63, 07052012@34, 08132012@38,
- Methylprednisolone Acetate (P) 40 mg/ml, Lot #04242012@91, 06272012@7, 08082012@103
- Methylprednisolone Acetate (PF) 80 mg/ml, Lot # 04162012@108, 05012012@74, 06082012@63, 07052012@34, 08132012@38
- Methylprednisolone Acetate (P) 80 mg/ml, Lot #04062012@44, 05222012@13, 07302012@72
Sterile intrathecal products recall by NECC
- Betamethasone repository (PF) 6 mg/ml – ALL LOTS
- Betamethasone repository (P) 6 mg/ml – ALL LOTS
- Betamethasone sodiumphosphate (PF) 6 mg/ml – ALL LOTS
- Betamethasone sodium phosphate (P) 6 mg/ml – ALL LOTS
- Betamethasone sodiumphosphate (PF) 8 mg/ml – ALL LOTS
- Betamethasone sodiumphosphate (PF) 12 mg/ml – ALL LOTS
- Bupivicaine (PF) 0.25% – ALL LOTS
- Bupivicaine(PF) 0.5% – ALL LOTS
- Bupivicaine(PF) 0.75 – ALL LOTS
- Clonidine (PF) 100 mcg/ml – ALL LOTS
- Dexamethasone sodiumphosphate (PF) 4 mg/ml – ALL LOTS
- Dexamethasone sodiumphosphate(PF) 6 mg/ml – ALL LOTS
- Dexamethasone sodiumphosphate(PF) 8 mg/ml – ALL LOTS
- Dexamethasone sodiumphosphate(PF) 10 mg/ml – ALL LOTS
- Glycerin (PF) 100% – ALL LOTS
- Hyaluronidase (PF) 150 u/ml – ALL LOTS
- lsovue (PF) 200 mg/ml – ALL LOTS
- lsovue (PF) 300 mg/ml – ALL LOTS
- Lidocaine/Dextrose (PF) 5%/7.5% – ALL LOTS
- Lidocaine (PF) 1% – ALL LOTS
- Lidocaine (PF) 2% – ALL LOTS
- Lidocaine (PF) 4% – ALL LOTS
- Omnipaque (PF) 240mg/ml – ALL LOTS
- Omnipaque (PF) 300mg/ml – ALL LOTS
- Saline (PF) 10% – ALL LOTS
- Saline (PF) 3% – ALL LOTS
- Triamcinolone – 10 mg/ml (P) – ALL LOTS
- Triamcinolone – 40 mg/ml (PF) – ALL LOTS
- Triamcinolone – 40 mg/ml (P) – ALL LOTS
- Triamcinolone – 80 mg/ml (PF) – ALL LOTS
Fungus has been identified in specimens obtained from at least four patients to date, including one of the patients who died. The FDA has also found a contaminant in an unopened vial of the recalled methylprednisolone acetate injection. The evidence is building up against NECC, and our meningitis lawyers are prepared to use it to sue NECC on behalf of victims and families. Contact Fred and David now for a free consultation here. They represent meningitis and stroke victims nationwide.
It is likely that there will be many, many more cases of meningitis and stroke linked to these recalled products, so contact our lawyers if you suspect you or a family member is part of this outbreak. The recalled products were distributed to clinics in the following states:
California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas, and West Virginia.
